Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Epirus Biopharma (EPRSQ)
OTHER OTC:EPRSQ
Epirus Biopharma (EPRSQ) Financial Statements
20 Followers
Epirus Biopharma Financial Overview
| Mar 16 | Dec 15 | Sep 15 | Jun 15 | Mar 15 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | $ 803.00K | $ 410.00K | $ 221.00K | $ 45.00K | $ 25.00K |
| Gross Profit | - | $ 285.00K | $ 221.00K | $ 45.00K | $ 25.00K |
| EBIT | $ -16.01M | $ -16.03M | $ -14.04M | $ -15.01M | $ -7.22M |
| EBITDA | $ -15.72M | $ -15.73M | $ -13.93M | $ -14.92M | $ -7.13M |
| Net Income Common Stockholders | $ -16.27M | $ -15.39M | $ -13.99M | $ -15.29M | $ -7.52M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 20.86M | $ 31.52M | $ 44.42M | $ 58.29M | $ 61.55M |
| Total Assets | $ 61.34M | $ 72.26M | $ 87.07M | $ 87.48M | $ 91.48M |
| Total Debt | $ 14.85M | $ 14.83M | $ 14.83M | $ 14.81M | $ 7.30M |
| Net Debt | $ -6.01M | $ -16.68M | $ -29.59M | $ -43.47M | $ -54.25M |
| Total Liabilities | $ 35.17M | $ 35.90M | $ 36.37M | $ 28.37M | $ 17.86M |
| Stockholders Equity | $ 26.17M | $ 36.37M | $ 50.70M | $ 59.11M | $ 73.62M |
| Cash Flow | - | ||||
| Free Cash Flow | $ -10.69M | $ -16.81M | $ -11.37M | $ -10.69M | $ -8.19M |
| Operating Cash Flow | $ -10.62M | $ -16.46M | $ -11.29M | $ -10.65M | $ -8.19M |
| Investing Cash Flow | $ -70.00K | $ 3.53M | $ -2.65M | $ -46.00K | $ 0.00 |
| Financing Cash Flow | $ 18.00K | $ 37.00K | $ 73.00K | $ 7.43M | $ 48.27M |
Epirus Biopharma Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.